True Wealth Design
VRTX icon

True Wealth Design’s Vertex Pharmaceuticals VRTX Stock Holding History

True Wealth Design’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$95.2K Buy
182
+9
+5% +$4.61K 0.02% 299
2026
Q2 		$85.9K Buy
173
+127
+276% +$56.3K 0.02% 300
2026
Q1 		$20.5K Buy
46
+34
+283% +$15.9K 0.01% 705
2025
Q4 		$5.44K Buy
12
+2
+20% +$862 ﹤0.01% 1056
2025
Q3 		$3.73K Sell
10
-18
-64% -$7.52K ﹤0.01% 1198
2025
Q2 		$12.3K Buy
28
+1
+4% +$461 ﹤0.01% 507
2025
Q1 		$12.9K Buy
27
+17
+170% +$7.92K ﹤0.01% 416
2024
Q4 		$3.83K Buy
10
+3
+43% +$1.39K ﹤0.01% 585
2024
Q3 		$3.26K Hold
7
– – ﹤0.01% 671
2024
Q2 		$3.28K Buy
7
+2
+40% +$868 ﹤0.01% 307
2024
Q1 		$2.09K Buy
5
+2
+67% +$845 ﹤0.01% 342
2023
Q4 		$1.22K Hold
3
– – ﹤0.01% 335
2023
Q3 		$1.04K Hold
3
– – ﹤0.01% 316
2023
Q2 		$1.06K Sell
3
-6
-67% -$2.02K ﹤0.01% 322
2023
Q1 		$2.84K Buy
9
+6
+200% +$1.8K ﹤0.01% 310
2022
Q4 		$866 Buy
+3
New +$914 ﹤0.01% 355

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

True Wealth Design's VRTX Position: Q3 2026 in Review

True Wealth Design increased its Vertex Pharmaceuticals (VRTX) stake by 5.2% in Q3 2026, buying an estimated $4.61K and bringing the position to 182 shares worth $95.2K. The position accounts for 0.02% of the portfolio, ranked #299.

True Wealth Design first reported a position in VRTX in Q4 2022 and has held it in 16 quarters since. 378 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • True Wealth Design held 182 shares of Vertex Pharmaceuticals worth $95.2K as of Q3 2026.
  • True Wealth Design bought 9 Vertex Pharmaceuticals shares in Q3 2026, an estimated $4.61K.
  • Vertex Pharmaceuticals made up 0.02% of True Wealth Design's portfolio in Q3 2026, its #299 holding.
  • True Wealth Design first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • 378 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.